Cardiology 2013 (Full reference info)

Reference Type: Journal Article
Record Number: 823Author: Anker, M. S., von Haehling, S., Springer, J., Banach, M. and Anker, S. D.
Year: 2013
Title: Highlights of the mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology
Journal: Int J Cardiol
Volume: 162
Issue: 2
Pages: 73-6
Date: Jan 10
Short Title: Highlights of the mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology
Alternate Journal: International journal of cardiology
ISSN: 1874-1754 (Electronic)
0167-5273 (Linking)
DOI: 10.1016/j.ijcard.2012.10.018
Accession Number: 23174169
Keywords: Biomedical Research
Cachexia/*drug therapy/*physiopathology
Cardiovascular Diseases/drug therapy/physiopathology
Ghrelin/therapeutic use
Humans
Lipolysis/physiology
Muscular Atrophy/physiopathology
Sarcopenia/*drug therapy/*physiopathology
Abstract: Sarcopenia and cachexia are significant medical problems with a high disease related burden in cardiovascular illness. Muscle wasting and weight loss are very frequent particularly in chronic heart failure and they relate to poor prognosis. Although clinically largely underestimated, the fields of cachexia and sarcopenia are of great relevance to cardiologists. In cachexia and sarcopenia a significant number of research publications related to basic science questions of muscle wasting and lipolysis were published between 2010 and 2012. Recently, the two processes of muscle wasting and lipolysis were found to be closely linked. Treatment research in pre-clinical models involves studies on a number of different therapeutic entities, including ghrelin, selective androgen receptor modulators (SARMs), as well as drugs targeting myostatin or melanocortin-4. In the human setting, studies using enobosarm (a SARM) and anamorelin (ghrelin) are in phase III. The last 3 years has seen significant efforts to define the field using consensus statements. In the future, these definitions should also be considered for guidelines and treatment trials in cardiovascular medicine. The current review aims to summarize important information and development in the fields of muscle wasting, sarcopenia and cachexia focussing on findings in cardiovascular research, in order for cardiologists to have a better understanding of the progress in the still not well enough known field.
Notes: Anker, Markus S
von Haehling, Stephan
Springer, Jochen
Banach, Maciej
Anker, Stefan D
eng
Review
Netherlands
2012/11/24 06:00
Int J Cardiol. 2013 Jan 10;162(2):73-6. doi: 10.1016/j.ijcard.2012.10.018. Epub 2012 Nov 20.
URL: http://www.ncbi.nlm.nih.gov/pubmed/23174169
Author Address: Center for Clinical and Basic Research, IRCCS San Raffaele, Rome, Italy.

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155